Main
>
ONCOLOGY (**)
>
Leukemia>Myeloid>Acute>IDH2+ R/R*
>
Treatment
>
Co: USA. C. Enasidenib
>
(*) USA Approval Date: 2017. 08.01
(*) USA Approval Date: 2017. 08.01's products
This section has no products